Cargando…
Linderalactone Suppresses Pancreatic Cancer Development In Vitro and In Vivo via Negatively Regulating PI3K/AKT Signaling Pathway
Linderalactone is one of the main extracts of Linderae Radix, which is widely used in traditional Chinese medicine. There have been few studies on the antitumor effect of linderalactone in the past. In this study, we explored the anti-pancreatic cancer activity of linderalactone in vitro and in vivo...
Autores principales: | Xu, Dongchao, Tian, Mengyao, Chen, Wangyang, Bian, Ying, Xia, Xiaofeng, Liu, Qiang, Zheng, Liyun, Zhang, Xiaofeng, Shen, Hongzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371883/ https://www.ncbi.nlm.nih.gov/pubmed/35966890 http://dx.doi.org/10.1155/2022/8675096 |
Ejemplares similares
-
Cucurbitacin I inhibits the proliferation of pancreatic cancer through the JAK2/STAT3 signalling pathway in vivo and in vitro
por: Xu, Dongchao, et al.
Publicado: (2022) -
Identification of novel immune-related targets mediating disease progression in acute pancreatitis
por: Liu, Qiang, et al.
Publicado: (2022) -
Identification of linderalactone as a natural inhibitor of SHP2 to ameliorate CCl(4)-induced liver fibrosis
por: Zhang, Yi, et al.
Publicado: (2023) -
The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma
por: Shen, Hongzhang, et al.
Publicado: (2021) -
Risk Factors for Carbapenem Resistant Gram Negative Bacteria (CR-GNB) Carriage Upon Admission to the Gastroenterology Department in a Tertiary First Class Hospital of China: Development and Assessment of a New Predictive Nomogram
por: Zhang, Hongchen, et al.
Publicado: (2022)